High Net Worth Advisory Group
PDSB icon

High Net Worth Advisory Group’s PDS Biotechnology PDSB Stock Holding History

High Net Worth Advisory Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$8K – 713
2021
Q4 		$8K Buy
+1,000
New +$10.8K ﹤0.01% 563

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Inspirion Wealth Advisors
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

High Net Worth Advisory Group's PDSB Position: Q1 2022 in Review

High Net Worth Advisory Group sold out of PDS Biotechnology (PDSB) in Q1 2022, closing a stake of 1,000 shares — an estimated $8K sold.

High Net Worth Advisory Group first reported a position in PDSB in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q1 2022.

  • High Net Worth Advisory Group reported no remaining PDS Biotechnology position as of Q1 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 1,000 PDS Biotechnology shares in Q1 2022, an estimated $8K.
  • High Net Worth Advisory Group first reported a position in PDS Biotechnology in Q4 2021 and held it in 1 quarter.
  • High Net Worth Advisory Group's PDS Biotechnology position peaked at $8K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2022.

Based on High Net Worth Advisory Group's 13F filing for Q1 2022, filed 13 May 2022.